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Abstract
Background—We examined risks associated with joint exposure to gene variants and pesticides.
Methods—Analyses included 189 cases and 390 male controls born from 1991-2003 in 
California's San Joaquin Valley. We used logistic regression to examine risks associated with joint 
exposures to gene variants and pesticides that our previous work identified as associated with 
hypospadias. Genetic variables were based on variants in DGKK; genes involved in sex steroid 
synthesis/metabolism; and genes involved in genital tubercle development. Pesticide exposure was 
based on residential proximity to commercial agricultural pesticide applications.
Results—Odds ratios (ORs) were highest among babies with joint exposures, who had 2- to 4-
fold increased risks; e.g., the OR was 3.7 (95% CI 0.8-16.5) among subjects with the risk-
associated DGKK haplotype and pesticide exposure; 1.5 (0.7-3.1) among subjects with the 
haplotype and no pesticide exposure; and 0.9 (0.5-1.6) among subjects without the haplotype but 
with pesticide exposure, relative to subjects with neither. However, results did not provide 
statistical evidence that these risks were significantly greater than expected on an additive scale, 
relative to risks associated with one exposure at a time.
Conclusions—We observed elevated risks associated with joint exposures to selected pesticides 
and genetic variants but no statistical evidence for interaction.
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Hypospadias, which occurs when the urethral opening occurs on the ventral side of the 
penis, affects around 5 per 1,000 newborn males (Carmichael and others, 2012b). Given the 
necessity of dihydro-testosterone to normal urethral closure in males, as well as 
experimental evidence indicating that estrogenic or anti-androgenic substances can disrupt 
this process (Gray and others, 2004; Noriega and others, 2005; Ostby and others, 1999), it is 
suspected that endocrine-disrupting environmental exposures may affect hypospadias risk. 
Pesticides, some of which are endocrine disruptors, have received the most attention. Most 
previous studies have been based on occupation as a proxy for exposure, and results have 
suggested modest to no association (Carmichael and others, 2012b), although a recent study 
of occupational exposures suggested stronger risks (Kalfa and others, 2015). We previously 
reported increased risk with residential proximity to a few – but not most – of many different 
pesticides that were studied (Carmichael and others, 2013b). Hypospadias is also highly 
heritable (Schnack and others, 2008), but the specific genes that contribute to risk are in 
large part unknown. Strong candidates include DGKK, which was discovered through a 
genome-wide association study (van der Zanden and others, 2010), as well as genes 
associated with genital tubercle development (the anlage for the penis) and sex steroid 
synthesis and metabolism (Carmichael and others, 2012b). We previously reported an 
association of hypospadias risk with variants in DGKK and a variety of genes that contribute 
to these processes (Carmichael and others, 2013a; Carmichael and others, 2012a; 
Carmichael and others, 2014). The pathway by which DGKK affects hypospadias risk is 
unknown.
Ultimately, it is expected that a combination of genetic and environmental factors will 
underlie risk of hypospadias. Thus, the objective of the current analysis was to examine the 
joint effects of genetic variants and residential proximity to specific agricultural pesticide 
applications on hypospadias risk. Our hypothesis was that risks would be highest among 
women who had pesticide exposures and whose babies had genetic variants that we 
previously identified as being associated with hypospadias risk. The analysis is based on our 
previous findings for the individual effects of these exposures in a large population-based 
cohort of California births (Carmichael and others, 2013a; Carmichael and others, 2012a; 
Carmichael and others, 2014; Carmichael and others, 2013b).
Methods
The study population included male infants born from 1991-2003 to mothers who were 
residents of eight California Central Valley counties (Fresno, Kern, Kings, Madera, Merced, 
San Joaquin, Stanislaus, and Tulare counties) and who were included in our previous studies 
of pesticides and genes and hypospadias (Carmichael and others, 2013a; Carmichael and 
others, 2012a; Carmichael and others, 2014; Carmichael and others, 2013b). California Birth 
Defects Monitoring Program staff ascertained cases by reviewing medical records at 
hospitals and genetic centers (Croen and others, 1991). Cases with known syndromes or 
single gene disorders, based on information available from medical records, were excluded. 
Cases were classified by hypospadias severity, which was based on the reported anatomical 
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position of the urethral opening. Mild cases were those for which the meatus was limited to 
the coronal or glanular penis (British Pediatric Association [BPA] codes 752.605, 752.625), 
moderate cases were those for which the meatus was on the penile shaft, and severe cases 
were those for which the meatus was at the peno-scrotal junction or perineal area (BPA 
codes 752.606, 752.607, 752.626, 752.627) (Carmichael and others, 2003). Cases for which 
the anatomical position was described as “not otherwise specified” (BPA codes 752.600, 
752.620) were ineligible, as were cases with a known single gene disorder or chromosomal 
abnormality. Male controls were randomly selected from all males who did not have major 
congenital malformations and were delivered in the same counties and years as the cases, to 
give an approximately 2:1 ratio of controls to cases. Registry data are routinely linked with 
vital statistics, from which we derived descriptive information (e.g., maternal race-ethnicity).
Cases and controls were linked with archived bloodspots that were collected for newborn 
screening, which served as the source of DNA for genotyping. TagSNPs with minor allele 
frequencies (MAF) >10% were selected for study using the Genome Variation Server (http://
gvs.gs.washington.edu/GVS/) and assayed using a custom multiplex Illumina GoldenGate 
assay. We used genotype information on 102 ancestry informative markers (AIMs) to create 
variables that reflect proportion Native American, African, and European ancestry for each 
study subject (Carmichael and others, 2014; Choudhry and others, 2010; Gamboa-Melendez 
and others, 2012; Risch and others, 2009; Via and others, 2010). Given that the three 
proportions sum to one, we only incorporated two (Native American and African) into our 
analyses to adjust for potential population stratification.
Genetic variables were defined based on the following: 1) for DGKK, we classified subjects 
as having a high-risk haplotype observed in our previous work, or not (block 2 haplotype #6, 
TTGCCGTA) (Carmichael and others, 2012a); 2) for genes associated with sex steroid 
synthesis and metabolism, we classified subjects as having risk-associated SNPs in 0, 1 or 2 
or more genes in this set (based on p<0.01) because the frequency of having an at-risk 
variant in any of these genes was so high (72% among controls); and 3) for genes associated 
with genital tubercle development, we classified subjects as having any versus no risk-
associated SNP for any of the genes in this set (i.e., p<0.01), based on previous analyses 
(Carmichael and others, 2013a). Sex steroid-related genes with risk-associated variants 
included HSD17B3, HSD3B1, SRD5A2, STARD3 and STS. Genital tubercle-related genes 
with risk-associated variants included BMP7, FGF10, GLI1 and GLI2.
We defined early pregnancy exposure as agricultural pesticide applications within a 500 m 
radius of maternal residence, using detailed data on applications and land use (details are 
provided elsewhere) (Carmichael and others, 2013b). The time window evaluated was 1-14 
weeks of embryonic age (i.e., 1-98 days post-conception), which approximately 
encompasses the time of genital tubercle and urethral development and closure (Shoenwolf 
and others, 2009), as well as several weeks preceding it, given the potential physiologic 
persistence of some pesticides. Last menstrual period was derived primarily from birth 
certificates. To estimate pesticide applications, we obtained Pesticide Use Reporting records 
from the California Department of Pesticide Regulation describing agricultural pesticide 
applications and spatially referenced them to public land survey sections and land-use 
survey field polygons from the California Department of Water Resources. We then used the 
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California Environmental Health Tracking Program Pesticide Linkage Tool to assign 
exposure to specific pesticides and physicochemical groupings of pesticides. In addition, 
pesticides were noted as being endocrine disruptors (European-Commission, November 10, 
2000; Keith, 1997); having reproductive or developmental toxicity based on the California 
Proposition 65 list (California-Office-of-Environmental-Health-Hazard-Assessment, 2012); 
or as being a reproductive or development toxicant based on having a US EPA-determined 
Reference Dose (RfD) from a toxicological study with a reproductive or developmental 
endpoint (EPA, 2012).
Pesticide exposure was defined based on any versus no exposure to any specific pesticide or 
pesticide group that was associated with overall hypospadias risk based on our previous 
analyses (i.e., had a CI excluding 1.0 in our previous analyses of pesticides that included all 
hypospadias cases) (Carmichael and others, 2013b). Associated pesticides included 
monochlorophenoxy acid or ester herbicides; the insecticides aldicarb, dimethoate, phorate, 
and petroleum oils; and the adjuvant polyoxyethylene sorbitol.
There were 196 cases and 420 controls born in Central Valley counties from 1991-2003 who 
had pesticide exposure assessment and genetic data. Among these subjects, 189 cases and 
390 controls had data on the ancestral informative marker variables and maternal race-
ethnicity. We incorporated the maximum number of subjects available into each comparison, 
which varied depending on the specific gene set being evaluated.
Logistic regression was used to generate odds ratios and 95% confidence intervals for the 
association of each combination of pesticide and genetic variables with hypospadias. All 
models also included variables reflecting genetic markers for ancestry (i.e., AIMs, see 
above) and maternal self-reported race-ethnicity (non-Hispanic white, Hispanic, other). In 
addition, we estimated the relative excess risk due to interaction (RERI) and its 95% CI to 
reflect additive interaction, which makes sense biologically and has more power than testing 
interaction on the multiplicative scale (Andersson and others, 2005; Correa and others, 
2012). This research was approved by the California Committee for the Protection of Human 
Subjects.
Results
Mothers of cases were more likely than controls to be non-Hispanic white, have greater than 
high school education, and to have had no previous live births, and less likely to be <25 
years old (Table 1). Case infants were more likely than control infants to have birthweight 
≤2500 gm and be delivered at <37 weeks gestation. Among the 189 cases, 62 were mild, 75 
were moderate, and 52 were severe. Frequencies of each of the genetic- and pesticide-related 
variables among cases and controls are shown in Table 2.
Odds ratios were highest for infants who had risk-associated genetic variants and whose 
mothers had residential pesticide exposure, versus subjects with neither (Table 3). For 
example, the odds ratio was 3.7 (95% CI 0.8, 16.5) among subjects with the risk-associated 
DGKK haplotype and pesticide exposure. An OR of 1.5 (95% CI 0.7, 3.1) was observed 
among subjects with the haplotype and no pesticide exposure, indicating that risk was 2.5 
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times higher (3.7/1.5) among the pesticide-exposed subjects. In contrast, among subjects 
without the risk-associated haplotype, the odds ratio was 0.9 (95% CI 0.5, 1.6) among 
subjects who did versus did not have the pesticide exposure.
Similarly, among subjects with risk-associated variants in two or more of the sex steroid-
related genes, the ORs were 4.4 (95% CI 1.8, 10.6) and 2.2 (95% CI 1.2, 3.8) among women 
with or without any pesticide exposure, i.e., 2.0 times higher among babies born to women 
with pesticide exposure. In contrast, among subjects with risk-associated variants in only 1 
of these genes, the ORs for women with and without pesticide exposure were 1.3 (95% CI 
0.5, 3.5) and 1.5 (95% CI 0.9, 2.6), i.e., not higher among babies born to women with 
pesticide exposure; among subjects with no risk-associated variants, the OR for pesticide 
exposure was not calculated due to small cell sizes (Table 3).
For genes related to genital tubercle development, we did not observe the same pattern; that 
is, odds ratios tended to be similar among subjects who had a risk-associated genetic variant 
regardless of whether or not they had pesticide exposure (Table 3).
The RERIs were positive. However, none of their confidence intervals excluded zero; i.e., 
statistical evidence was lacking that the association of hypospadias risk with the selected 
pesticides and genetic variants in combination was greater than expected (95% CIs for all 
RERI's included zero).
Discussion
We examined risks associated with joint exposure to gene variants and pesticides that we 
previously observed to be independently associated with risk of hypospadias. As expected, 
the highest risks were among babies with both exposures, indicating 2- to 4-fold increased 
risks among babies with both exposures. However, our results did not provide statistical 
evidence that these increased risks were significantly greater than expected on an additive 
scale, based on risks associated with one exposure at a time. Our inability to detect such a 
departure may in part reflect the fact that the number of subjects with joint gene and 
pesticide exposures was relatively small.
Our study is unique in the genetic variants and pesticide exposures it investigated, as well as 
its examination of these factors in combination; as such, it is challenging to compare it to 
prior studies. Multiple review papers have discussed the potential contribution of gene-
environment interaction to hypospadias risk (Marrocco and others, 2015; Thorup and others, 
2014). We are aware of one study that examined gene-environment interaction(van der 
Zanden and others, 2012). The study reported evidence for interaction between one SNP in 
SRD5A2 (rs523349, or V89L) and ‘exogenous estrogen’ exposure (which included oral 
contraceptive use or intake of soy or linseed-based foods; the OR for both exposures was 
8.5, 95% CI 1.1-67.8); the SRD5A2 SNP and maternal hypertensive disorders (OR 0.6, 95% 
CI 0.3-1.1); and one SNP in ATF3 rs11119982) and ‘cytokine’ exposure (which included 
maternal cold, infection or immune-related disease; the OR was 2.8, 95% CI 1.3-6.4).
Our study's strengths include its population-based design and thorough case ascertainment. 
The registry has the advantage of being based on detailed clinical information at the 
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population-level. We were able to distinguish cases based on severity but did not do so based 
on reported minor accompanying genital malformations (e.g., cryptorchidism, micropenis), 
given that their ascertainment by the registry is less accurate and complete than it is for more 
major malformations; the potential impact on results is uncertain. Pesticide exposure 
assessment was more detailed than prior studies but still has limitations, such as being 
focused on residential proximity to pesticide applications rather than more direct 
measurements of exposure levels such as serum levels, and inability to consider non-
residential exposures. In addition, pesticide exposure was based on residence at birth rather 
than during the periconceptional period; the extent of error incurred by residential mobility 
is uncertain but likely to be non-differential (i.e., similar for cases and controls). Data on 
DGKK haplotypes was missing on >15% of subjects, because haplotype characterization 
required non-missing data on all measured variants. We are unaware of any reason to believe 
that estimates based on the sub-sample with complete data would be biased. Genetic variants 
in a variety of genes were investigated, but ultimately they may represent a tiny proportion 
of variants that may contribute to hypospadias risk or the potential negative effects of 
pesticide exposures. It was not feasible to further extend the amount of genetic information 
available on each case. A strength of our genetic work is the inclusion of ancestry 
informative markers; however, adjustment for them did not substantially alter results (data 
not shown).
This study indicates that babies with genetic variants and maternal pesticide exposures who 
were previously identified as associated with increased risk of hypospadias were at 2- to 4-
fold increased risk of hypospadias. The magnitudes of risk were greatest among babies with 
joint exposures, but the analysis did not provide statistical evidence for interaction. Our 
results should be interpreted with caution, given that they represent the first report of joint 
effects of the studied exposures, and they are based on findings related to independent 
effects that are also unique.
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Table 1
Descriptive characteristics of hypospadias cases (n=189) and unaffected male controls (n=390), California, 
1991-2003.
Percent of Cases (n) Percent of Controls (n)
Maternal race-ethnicity
    Non-Hispanic white 48 (90) 37 (143)
    Hispanic 38 (72) 46 (180)
    Others 14 (27) 17 (67)
Maternal education
    < High school 29 (54) 41 (159)
    High school 31 (58) 34 (131)
    > High school 40 (75) 25 (96)
    Unknown 1 (2) 1 (4)
Maternal age
    < 25 years 39 (73) 52 (202)
    25-34 years 49 (93) 40 (155)
    35 or more years 12 (23) 8 (33)
Number of previous live births
    0 50 (94) 33 (129)
    1 29 (55) 31 (122)
    ≥ 2 21 (40) 36 (139)
    Unknown 0 (0) 0 (0)
Infant birthweight
    ≤ 2500 g 33 (63) 6 (23)
    > 2500 g 66 (124) 94 (367)
    Unknown 1 (2) 0 (0)
Gestational age at delivery
    < 37 weeks 27 (51) 9 (37)
    ≥ 37 weeks 71 (135) 84 (327)
    Unknown 2 (3) 7 (26)
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Table 2
Frequency of genetic variant and pesticide exposure variables among case (n=189) and male control (n=390) 
infants.*
Percent of cases (n) Percent of controls (n)
Risk-associated genetic variants
DGKK high-risk haplotype
    Yes 10 (19) 6 (22)
    No 74 (139) 74 (290)
    Missing 16 (31) 20 (78)
Risk-associated SNPs in sex steroid genes
    Any 83 (156) 72 (282)
    None 16 (31) 26 (100)
    Missing 1 (2) 2 (8)
Risk-associated SNPs in genital tubercle genes
    Any 28 (52) 16 (61)
    None 69 (131) 81 (314)
    Missing 3 (6) 4 (15)
Risk-associated pesticide exposure
    Any 13 (25) 12 (45)
    None 87 (164) 88 (345)
1 Details regarding definitions of genetic and pesticide variables are available in the Methods. In brief, for DGKK, subjects were designated as 
having a risk-associated haplotype or not; for sex steroid-related genes, 2 or more indicates that subjects had risk-associated variants in 2 or more 
different genes in this set of genes; and for genital tubercle-related genes, ‘Any’ indicates that subjects had risk-associated variants in any of the 
genes in this set. Pesticide exposure was based on residential proximity to commercial agricultural application of pesticides that we previously 
identified as being associated with hypospadias risk.
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Table 3








No. cases No. controls Odds ratio (95% 
CI) 
2 RERI (95% CI) 
3
DGKK Any Yes 5 3 3.7 (0.8, 16.5) 2.4 (−3.2, 8.0)
Any No 14 19 1.5 (0.7, 3.1)
None Yes 16 36 0.9 (0.5, 1.6)
None No 123 254 Reference
Sex hormone-related genes 2+ Yes 16 14 4.4 (1.8, 10.6) 3.1 (−0.7, 6.9)
2+ No 62 109 2.2 (1.2, 3.8)
1 Yes 7 16 1.3 (0.5, 3.5) 0.4 (−0.9, 1.7)
1 No 71 143 1.5 (0.9, 2.6)
0 Yes 2 15 -
0 No 29 85 Reference
Genital tubercle-related genes Any Yes 7 7 2.3 (0.8, 6.8) 0.2 (−2.4, 2.8)
Any No 45 54 1.9 (1.2, 3.2)
None Yes 18 37 1.1 (0.6, 2.1)
None No 113 277 Reference
1
Details regarding definitions of genetic and pesticide variables are available in the Methods. In brief, for DGKK, subjects were designated as 
having a risk-associated haplotype or not; for sex steroid-related genes, 2 or more indicates that subjects had risk-associated variants in 2 or more 
different genes in this set of genes; and for genital tubercle-related genes, ‘Any’ indicates that subjects had risk-associated variants in any of the 
genes in this set. Pesticide exposure was based on residential proximity to commercial agricultural application of pesticides that we previously 
identified as being associated with hypospadias risk.
2
Odds ratios are not reported for comparisons that involved cell sizes <3. Odds ratios are adjusted for genetic markers for ancestry (i.e., ancestry 
informative markers, as described in the Methods) and maternal self-reported race-ethnicity.
3
RERI = Relative excess risk due to interaction, which reflects departure from additivity of effects of exposure to pesticides and presence of genetic 
variants; a value of ‘0’ represents the null (no departure from additivity).
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